Latest California Healthline Stories
‘Right-To-Try’ Laws Expose Dying Patients To Exploitation, Ethicists Warn
More than 30 states have laws on the books to allow dying patients the right-to-try experimental treatments. But these treatments may not be covered by insurance, and ethicists worry vulnerable people could be exploited near the end of their lives. The laws may also duplicate a process the FDA already has in place.
Patient Advocacy Groups Rake In Donations From Pharma
A new study shows that 83 percent of the largest patient advocacy groups take contributions from drug, medical device or biotech firms.
Video Highlights: Trump Promises To Lower Cost Of Health Insurance
President Trump called on Republicans and Democrats to work together to repeal and replace Obamacare.
California Cancer Rates Dropped During The Recession. That’s Not Necessarily A Good Thing.
Researchers believe Californians, many of whom lost health coverage, delayed doctor visits that could have led to earlier detection. Now, with people seeking medical care under the Affordable Care Act, some experts expect to see an increase in late-stage cancers.
Instead Of Trashing A $600 EpiPen, Some Patients Get A Refill
Epinephrine, the active ingredient in EpiPens, expires after 18 months, and the auto-injector device can’t be refilled or reused. Health professionals are looking for work-arounds they say could save the health system millions.
President Trump And I Take The Same Drugs — Except One
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
Popular Charity Heart Screenings For Teens May Cause More Problems Than They Solve
The screenings with an electrocardiograms are often set up after a tragic death of a local athlete, but researchers say there is no evidence that they prevent deaths and may lead to false alarms and further unnecessary testing.
5 Reasons Why An $89,000 Drug Has Congress Fuming
A drug from Marathon Pharmaceuticals has ignited a firestorm on Capitol Hill and beyond. What makes it different than the $750,000 drug that came before it?
A Deep Dive Into 4 GOP Talking Points On Health Care
The president says Obamacare has been “a complete and total disaster,” and other Republicans see nothing but trouble. But a careful look at the arguments suggest the situation is more complicated.
Senator Grassley Launches Inquiry Into Orphan Drugs After KHN Investigation
Citing a Kaiser Health News investigation, Senate Judiciary Committee Chairman Chuck Grassley vows to examine the orphan drug program and possible fixes.